Copyright Reports & Markets. All rights reserved.

Global Hospital Acquired Urinary Tract Infection Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Hospital Acquired Urinary Tract Infection Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Hospital Acquired Urinary Tract Infection Market Size Growth Rate by Product
      • 1.4.2 Microbial Testing Instruments
      • 1.4.3 Reagents and Consumables
      • 1.4.4 Infection Prevention and Surveillance Software
    • 1.5 Market by End User
      • 1.5.1 Global Hospital Acquired Urinary Tract Infection Market Size Growth Rate by End User
      • 1.5.2 Disease Testing
      • 1.5.3 Drug-resistance Testing
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Hospital Acquired Urinary Tract Infection Market Size
      • 2.1.1 Global Hospital Acquired Urinary Tract Infection Revenue 2014-2025
      • 2.1.2 Global Hospital Acquired Urinary Tract Infection Sales 2014-2025
    • 2.2 Hospital Acquired Urinary Tract Infection Growth Rate by Regions
      • 2.2.1 Global Hospital Acquired Urinary Tract Infection Sales by Regions
      • 2.2.2 Global Hospital Acquired Urinary Tract Infection Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Hospital Acquired Urinary Tract Infection Sales by Manufacturers
      • 3.1.1 Hospital Acquired Urinary Tract Infection Sales by Manufacturers
      • 3.1.2 Hospital Acquired Urinary Tract Infection Sales Market Share by Manufacturers
      • 3.1.3 Global Hospital Acquired Urinary Tract Infection Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hospital Acquired Urinary Tract Infection Revenue by Manufacturers
      • 3.2.1 Hospital Acquired Urinary Tract Infection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hospital Acquired Urinary Tract Infection Revenue Share by Manufacturers (2014-2019)
    • 3.3 Hospital Acquired Urinary Tract Infection Price by Manufacturers
    • 3.4 Hospital Acquired Urinary Tract Infection Manufacturing Base Distribution, Product Types
      • 3.4.1 Hospital Acquired Urinary Tract Infection Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Hospital Acquired Urinary Tract Infection Product Type
      • 3.4.3 Date of International Manufacturers Enter into Hospital Acquired Urinary Tract Infection Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Hospital Acquired Urinary Tract Infection Sales by Product
    • 4.2 Global Hospital Acquired Urinary Tract Infection Revenue by Product
    • 4.3 Hospital Acquired Urinary Tract Infection Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Hospital Acquired Urinary Tract Infection Breakdown Data by End User

    6 North America

    • 6.1 North America Hospital Acquired Urinary Tract Infection by Countries
      • 6.1.1 North America Hospital Acquired Urinary Tract Infection Sales by Countries
      • 6.1.2 North America Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Hospital Acquired Urinary Tract Infection by Product
    • 6.3 North America Hospital Acquired Urinary Tract Infection by End User

    7 Europe

    • 7.1 Europe Hospital Acquired Urinary Tract Infection by Countries
      • 7.1.1 Europe Hospital Acquired Urinary Tract Infection Sales by Countries
      • 7.1.2 Europe Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Hospital Acquired Urinary Tract Infection by Product
    • 7.3 Europe Hospital Acquired Urinary Tract Infection by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Hospital Acquired Urinary Tract Infection by Countries
      • 8.1.1 Asia Pacific Hospital Acquired Urinary Tract Infection Sales by Countries
      • 8.1.2 Asia Pacific Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Hospital Acquired Urinary Tract Infection by Product
    • 8.3 Asia Pacific Hospital Acquired Urinary Tract Infection by End User

    9 Central & South America

    • 9.1 Central & South America Hospital Acquired Urinary Tract Infection by Countries
      • 9.1.1 Central & South America Hospital Acquired Urinary Tract Infection Sales by Countries
      • 9.1.2 Central & South America Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Hospital Acquired Urinary Tract Infection by Product
    • 9.3 Central & South America Hospital Acquired Urinary Tract Infection by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Hospital Acquired Urinary Tract Infection by Countries
      • 10.1.1 Middle East and Africa Hospital Acquired Urinary Tract Infection Sales by Countries
      • 10.1.2 Middle East and Africa Hospital Acquired Urinary Tract Infection Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Hospital Acquired Urinary Tract Infection by Product
    • 10.3 Middle East and Africa Hospital Acquired Urinary Tract Infection by End User

    11 Company Profiles

    • 11.1 Advanced Sterilization Products
      • 11.1.1 Advanced Sterilization Products Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Products Offered
      • 11.1.5 Advanced Sterilization Products Recent Development
    • 11.2 Becton
      • 11.2.1 Becton Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Becton Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Becton Hospital Acquired Urinary Tract Infection Products Offered
      • 11.2.5 Becton Recent Development
    • 11.3 Dickinson and Company
      • 11.3.1 Dickinson and Company Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Dickinson and Company Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Dickinson and Company Hospital Acquired Urinary Tract Infection Products Offered
      • 11.3.5 Dickinson and Company Recent Development
    • 11.4 Steris Corporation
      • 11.4.1 Steris Corporation Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Steris Corporation Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Steris Corporation Hospital Acquired Urinary Tract Infection Products Offered
      • 11.4.5 Steris Corporation Recent Development
    • 11.5 Getinge Group
      • 11.5.1 Getinge Group Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Getinge Group Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Getinge Group Hospital Acquired Urinary Tract Infection Products Offered
      • 11.5.5 Getinge Group Recent Development
    • 11.6 Kimberly-Clark Corporation
      • 11.6.1 Kimberly-Clark Corporation Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Products Offered
      • 11.6.5 Kimberly-Clark Corporation Recent Development
    • 11.7 Cantel Medical
      • 11.7.1 Cantel Medical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Cantel Medical Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Cantel Medical Hospital Acquired Urinary Tract Infection Products Offered
      • 11.7.5 Cantel Medical Recent Development
    • 11.8 Biomerieux
      • 11.8.1 Biomerieux Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Biomerieux Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Biomerieux Hospital Acquired Urinary Tract Infection Products Offered
      • 11.8.5 Biomerieux Recent Development
    • 11.9 Belimed
      • 11.9.1 Belimed Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Belimed Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Belimed Hospital Acquired Urinary Tract Infection Products Offered
      • 11.9.5 Belimed Recent Development
    • 11.10 3M Company
      • 11.10.1 3M Company Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 3M Company Hospital Acquired Urinary Tract Infection Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 3M Company Hospital Acquired Urinary Tract Infection Products Offered
      • 11.10.5 3M Company Recent Development
    • 11.11 Sterigenics International
    • 11.12 Synergy Health
    • 11.13 PLC

    12 Future Forecast

    • 12.1 Hospital Acquired Urinary Tract Infection Market Forecast by Regions
      • 12.1.1 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Hospital Acquired Urinary Tract Infection Revenue Forecast by Regions 2019-2025
    • 12.2 Hospital Acquired Urinary Tract Infection Market Forecast by Product
      • 12.2.1 Global Hospital Acquired Urinary Tract Infection Sales Forecast by Product 2019-2025
      • 12.2.2 Global Hospital Acquired Urinary Tract Infection Revenue Forecast by Product 2019-2025
    • 12.3 Hospital Acquired Urinary Tract Infection Market Forecast by End User
    • 12.4 North America Hospital Acquired Urinary Tract Infection Forecast
    • 12.5 Europe Hospital Acquired Urinary Tract Infection Forecast
    • 12.6 Asia Pacific Hospital Acquired Urinary Tract Infection Forecast
    • 12.7 Central & South America Hospital Acquired Urinary Tract Infection Forecast
    • 12.8 Middle East and Africa Hospital Acquired Urinary Tract Infection Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Hospital Acquired Urinary Tract Infection Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.
      They are accountable for over 50% of infections.
      An array of tests can uncover type of infection and pathogen associated with the infection to efficiently treat the infected area.
      Increase in prevalence of hospital acquired UTIs and technological advancement in testing devices drive the market.
      The global Hospital Acquired Urinary Tract Infection market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hospital Acquired Urinary Tract Infection market based on company, product type, end user and key regions.

      This report studies the global market size of Hospital Acquired Urinary Tract Infection in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hospital Acquired Urinary Tract Infection in these regions.
      This research report categorizes the global Hospital Acquired Urinary Tract Infection market by top players/brands, region, type and end user. This report also studies the global Hospital Acquired Urinary Tract Infection market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Advanced Sterilization Products
      Becton
      Dickinson and Company
      Steris Corporation
      Getinge Group
      Kimberly-Clark Corporation
      Cantel Medical
      Biomerieux
      Belimed
      3M Company
      Sterigenics International
      Synergy Health
      PLC

      Market size by Product
      Microbial Testing Instruments
      Reagents and Consumables
      Infection Prevention and Surveillance Software
      Market size by End User
      Disease Testing
      Drug-resistance Testing

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Hospital Acquired Urinary Tract Infection market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Hospital Acquired Urinary Tract Infection market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Hospital Acquired Urinary Tract Infection companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Hospital Acquired Urinary Tract Infection submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Hospital Acquired Urinary Tract Infection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hospital Acquired Urinary Tract Infection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now